17-80273325-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001256071.3(RNF213):​c.182C>T​(p.Pro61Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0028 in 1,613,524 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P61P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0059 ( 10 hom., cov: 31)
Exomes 𝑓: 0.0025 ( 49 hom. )

Consequence

RNF213
NM_001256071.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.299

Publications

10 publications found
Variant links:
Genes affected
RNF213 (HGNC:14539): (ring finger protein 213) This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
RNF213 Gene-Disease associations (from GenCC):
  • Moyamoya disease 2
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037269592).
BP6
Variant 17-80273325-C-T is Benign according to our data. Variant chr17-80273325-C-T is described in ClinVar as Benign. ClinVar VariationId is 721038.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00587 (894/152238) while in subpopulation SAS AF = 0.0201 (97/4828). AF 95% confidence interval is 0.0169. There are 10 homozygotes in GnomAd4. There are 443 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256071.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNF213
NM_001256071.3
MANE Select
c.182C>Tp.Pro61Leu
missense
Exon 3 of 68NP_001243000.2A0A0A0MTR7
RNF213
NM_001410195.1
c.182C>Tp.Pro61Leu
missense
Exon 3 of 69NP_001397124.1A0A0A0MTC1
RNF213
NM_020914.5
c.182C>Tp.Pro61Leu
missense
Exon 3 of 69NP_065965.5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RNF213
ENST00000582970.6
TSL:1 MANE Select
c.182C>Tp.Pro61Leu
missense
Exon 3 of 68ENSP00000464087.1A0A0A0MTR7
RNF213
ENST00000319921.4
TSL:1
c.182C>Tp.Pro61Leu
missense
Exon 3 of 17ENSP00000324392.4Q63HN8-5
RNF213
ENST00000508628.6
TSL:5
c.182C>Tp.Pro61Leu
missense
Exon 3 of 69ENSP00000425956.2A0A0A0MTC1

Frequencies

GnomAD3 genomes
AF:
0.00576
AC:
876
AN:
152120
Hom.:
7
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0160
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0116
Gnomad SAS
AF:
0.0201
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00442
AC:
1105
AN:
250160
AF XY:
0.00487
show subpopulations
Gnomad AFR exome
AF:
0.0175
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00887
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000204
Gnomad OTH exome
AF:
0.00295
GnomAD4 exome
AF:
0.00248
AC:
3628
AN:
1461286
Hom.:
49
Cov.:
32
AF XY:
0.00294
AC XY:
2136
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.0168
AC:
563
AN:
33480
American (AMR)
AF:
0.00112
AC:
50
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0265
AC:
1051
AN:
39700
South Asian (SAS)
AF:
0.0187
AC:
1610
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52852
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000989
AC:
110
AN:
1111992
Other (OTH)
AF:
0.00379
AC:
229
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
246
492
737
983
1229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00587
AC:
894
AN:
152238
Hom.:
10
Cov.:
31
AF XY:
0.00595
AC XY:
443
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.0161
AC:
668
AN:
41532
American (AMR)
AF:
0.00209
AC:
32
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.0116
AC:
60
AN:
5176
South Asian (SAS)
AF:
0.0201
AC:
97
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68018
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
44
87
131
174
218
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00265
Hom.:
5
Bravo
AF:
0.00602
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0143
AC:
63
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00507
AC:
615
Asia WGS
AF:
0.0400
AC:
139
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.1
DANN
Benign
0.74
DEOGEN2
Benign
0.029
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.51
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.32
N
PhyloP100
-0.30
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.094
Sift
Benign
0.55
T
Sift4G
Benign
0.38
T
Vest4
0.092
MVP
0.12
MPC
0.33
ClinPred
0.0034
T
GERP RS
-4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9913317; hg19: chr17-78247124; COSMIC: COSV108843177; API